Characterization of thoracal fat depots – expression of adipokines and remodeling factors and impact of adipocyte conditioned media in fibroblast scratch assays
Restricted accessResearch articleFirst published online November 28, 2018
Characterization of thoracal fat depots – expression of adipokines and remodeling factors and impact of adipocyte conditioned media in fibroblast scratch assays
Adipose tissue is not only a connective tissue but also an endocrine organ secreting adipokines like Leptin and Adiponectin, lipokines such as palmitoileic acid and extracellular vesicles. These factors and the expression of matrix remodeling enzymes impact surrounding tissues via paracrine effects. The expression of selected secretion factors and the effect of adipocyte conditioned media from four thoracal adipose tissue origins - subcutaneous, perivascular, pericardial and epicardial adipose tissues – in a fibroblast proliferation/wound healing scratch assay model were investigated. Results were compared directly and according to the type 2 diabetic mellitus (T2DM) status of the patients the tissues are originated from. Adipocyte conditioned media from non-diabetic patients resulted in a significant higher scratch closure rate compared to the media with T2DM background. Linoleic acid incubation in scratch assay resulted in a reduced scratch closure rate. Leptin, Adiponectin and Visfatin/Nampt expression and MMP2, MMP9 and FSTL1 mRNA levels did not vary according to T2DM subgroups directly, leading to the assumption that these factors are not causal for scratch assay effects observed. In contrast significant mRNA expression differences were monitored between the thoracal tissue origins implying variations in the local effects of the different adipose tissue depots.
ChoiCHJ, CohenP. Adipose crosstalk with other cell types in health and disease. Exp Cell Res. 2017.
2.
TrujilloME, SchererPE. Adipose tissue-derived factors: Impact on health and disease. Endocr Rev. 2006;27(7):762–78.
3.
GonzalezN, Moreno-VillegasZ, Gonzalez-BrisA, EgidoJ, LorenzoO. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):44.
4.
BluherM, MantzorosCS. From leptin to other adipokines in health and disease: Facts and expectations at the beginning of the 21st century. Metabolism. 2015;64(1):131–45.
5.
CaoH. Adipocytokines in obesity and metabolic disease. J Endocrinol. 2014;220(2):T47–59.
6.
MaffeiM, HalaasJ, RavussinE, PratleyRE, LeeGH, ZhangY, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1(11):1155–61.
7.
LiS, ShinHJ, DingEL, van DamRM. Adiponectin levels and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA. 2009;302(2):179–88.
8.
FukuharaA, MatsudaM, NishizawaM, SegawaK, TanakaM, KishimotoK, et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307(5708):426–30.
9.
BerndtJ, KlotingN, KralischS, KovacsP, FasshauerM, SchonMR, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes. 2005;54(10):2911–6.
10.
DaiM, ZhangY, YuM, TianW. Therapeutic applications of conditioned medium from adipose tissue. Cell Prolif. 2016;49(5):561–7.
11.
FletcherSJ, SaccaPA, Pistone-CreydtM, ColoFA, SerraMF, SantinoFE, et al. Human breast adipose tissue: Characterization of factors that change during tumor progression in human breast cancer. J Exp Clin Cancer Res. 2017;36(1):26.
12.
Alvarez-LlamasG, SzalowskaE, de VriesMP, WeeningD, LandmanK, HoekA, et al. Characterization of the human visceral adipose tissue secretome. Mol Cell Proteomics. 2007;6(4):589–600.
13.
SkalnikovaH, MotlikJ, GadherSJ, KovarovaH. Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines. Proteomics. 2011;11(4):691–708.
14.
KoberJ, GugerellA, SchmidM, ZeydaM, BuchbergerE, NicklS, et al. Wound healing effect of conditioned media obtained from adipose tissue on human skin cells: A comparative in vitro study. Ann Plast Surg. 2016;77(2):156–63.
15.
MauryE, Ehala-AleksejevK, GuiotY, DetryR, VandenhooftA, BrichardSM. Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab. 2007;293(3):E656–65.
16.
DrososI, ChalikiasG, PavlakiM, KareliD, EpitropouG, BougioukasG, et al. Differences between perivascular adipose tissue surrounding the heart and the internal mammary artery: Possible role for the leptin-inflammation-fibrosis-hypoxia axis. Clin Res Cardiol. 2016;105(11):887–900.
AkoumianakisI, AntoniadesC. The interplay between adipose tissue and the cardiovascular system: Is fat always bad?Cardiovasc Res. 2017;113(9):999–1008.
19.
KimSH, DespresJP, KohKK. Obesity and cardiovascular disease: Friend or foe?Eur Heart J. 2016;37(48):3560–8.
20.
NishidaC, KoGT, KumanyikaS. Body fat distribution and noncommunicable diseases in populations: Overview of the WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr. 2010;64(1):2–5.
21.
HeitmannBL, LissnerL. Hip Hip Hurrah! Hip size inversely related to heart disease and total mortality. Obes Rev. 2011;12(6):478–81.
22.
VegiopoulosA, RohmM, HerzigS. Adipose tissue: Between the extremes. EMBO J. 2017;36(14):1999–2017.
23.
BaysH. Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction. Curr Opin Endocrinol Diabetes Obes. 2014;21(5):345–51.
24.
IacobellisG. Epicardial adipose tissue in endocrine and metabolic diseases. Endocrine. 2014;46(1):8–15.
25.
Siegel-AxelDI, HaringHU. Perivascular adipose tissue: An unique fat compartment relevant for the cardiometabolic syndrome. Rev Endocr Metab Disord. 2016;17(1):51–60.
26.
SchaferK, DrososI, KonstantinidesS. Perivascular adipose tissue: Epiphenomenon or local risk factor?Int J Obes (Lond). 2017;41(9):1311–23.
27.
PatelVB, ShahS, VermaS, OuditGY. Epicardial adipose tissue as a metabolic transducer: Role in heart failure and coronary artery disease. Heart Fail Rev. 2017.
28.
NagyE, JermendyAL, MerkelyB, Maurovich-HorvatP. Clinical importance of epicardial adipose tissue. Arch Med Sci. 2017;13(4):864–74.
29.
IacobellisG. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015;11(6):363–71.
30.
IacobellisG. Epicardial and pericardial fat: Close, but very different. Obesity (Silver Spring). 2009;17(4):625; author reply 6–7.
31.
PezeshkianM, MahtabipourMR. Epicardial and subcutaneous adipose tissue Fatty acids profiles in diabetic and non-diabetic patients candidate for coronary artery bypass graft. Bioimpacts. 2013;3(2):83–9.
32.
YimJ, RabkinSW. Differences in gene expression and gene associations in epicardial fat compared to subcutaneous fat. Horm Metab Res. 2017;49(05):327–37.
33.
Teijeira-FernandezE, EirasS, Grigorian-ShamagianL, Salgado-SomozaA, Martinez-ComendadorJM, Gonzalez-JuanateyJR. Diabetic and nondiabetic patients express similar adipose tissue adiponectin and leptin levels. Int J Obes (Lond). 2010;34(7):1200–8.
34.
CamarenaV, SantD, MohseniM, SalernoT, ZaleskiML, WangG, et al. Novel atherogenic pathways from the differential transcriptome analysis of diabetic epicardial adipose tissue. Nutr Metab Cardiovasc Dis. 2017;27(8):739–50.
35.
TadokoroS, IdeS, TokuyamaR, UmekiH, TateharaS, KataokaS, et al. Leptin promotes wound healing in the skin. PLoS One. 2015;10(3):e0121242.
36.
MuradA, NathAK, ChaST, DemirE, Flores-RiverosJ, Sierra-HonigmannMR. Leptin is an autocrine/paracrine regulator of wound healing. FASEB J. 2003;17(13):1895–7.
37.
KawaiK, KageyamaA, TsumanoT, NishimotoS, FukudaK, YokoyamaS, et al. Effects of adiponectin on growth and differentiation of human keratinocytes–implication of impaired wound healing in diabetes. Biochem Biophys Res Commun. 2008;374(2):269–73.
38.
JinCE, XiaoL, GeZH, ZhanXB, ZhouHX. Role of adiponectin in adipose tissue wound healing. Genet Mol Res. 2015;14(3):8883–91.
39.
IuonutA-MM, DindeleganGC. C. C. Proteases As Biomarkers In Wound Healing. . Timisoara medical Journal. 2011; 61(1-2).
40.
RohaniMG, ParksWC. Matrix remodeling by MMPs during wound repair. Matrix Biol. 2015;44-46:113–21.
